You just read:

Immunomic Therapeutics (ITI) and Lysosomal Associated Membrane Protein (LAMP) Based Nucleic Acid Immunotherapy Featured At 2016 World Vaccine Congress

News provided by

Immunomic Therapeutics, Inc.

Mar 29, 2016, 10:55 ET